Judith A. Hasko


  • Co-Chair, Life Sciences Practice

Judith Hasko serves as co-chair of WilmerHale’s Life Sciences Practice. She provides counsel to life sciences companies and their investors on strategic, intellectual property and technology-based commercial transactions. Companies in the biotechnology, pharmaceutical, medical device and diagnostic product sectors, along with their investors, depend on Ms. Hasko for guidance and execution of licensing, corporate partnerships, joint ventures, co-promotion arrangements, manufacturing and distribution agreements, asset purchases and royalty stream transactions.

Widely recognized for her market-leading transactional work, Ms. Hasko brings complementary business and scientific perspectives to her legal representations. Her work in the life sciences industry is consistently recognized by Chambers USA, The Legal 500 United States, IAM Patent and LMG Life Sciences. Ms. Hasko is a Certified Licensing Professional (CLP), and a member of the Patent Bar. Prior to attending law school, she was part of Genentech’s cardiovascular research department.

Prior to joining the firm, Ms. Hasko was a partner in the Silicon Valley office of another major international law firm, where served as vice chair of their Healthcare & Life Sciences Practice.

Professional Activities

Ms. Hasko has co-authored several scientific publications and frequently lectures on life sciences commercial topics in both industry and academic settings, including at Berkeley Law and Stanford University. 


  • Consistently ranked nationwide in Chambers USA Guide in the area of Life Sciences: Corporate/Commercial. 

Insights & News


  • Education

    • JD, University of Wisconsin Law School, 1994

    • MPhil, University of Sussex, 1988

    • BA, Vassar College, 1986

  • Admissions

    • California

    • US Patent and Trademark Office



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.